Production & Manufacturing

eschbach has renamed its flagship enterprise software platform, Shiftconnector, to Seqonis, marking a new phase in the product’s development after two decades of expansion across pharmaceutical, chemical and process manufacturing industries. The announcement was made during the Pharma Manufacturing...

The rapid and profound maturation of the global biopharmaceutical sector is being clearly marked by cell and gene therapy manufacturing entering GMP era. This critical transition involves the large-scale implementation of rigorous and uncompromising Good Manufacturing Practice standards to ensure that these complex, "living" treatments are produced with a level of consistent quality and safety that meets international requirements. By adopting highly automated systems, closed-loop processing, and robust, data-driven regulatory frameworks, the industry is successfully overcoming the historical hurdles of scalability and biological variability, paving the way for these advanced therapies to reach much broader patient populations across the globe.

Color consistency is critical in pharmaceutical quality control (QC). Variations in tablet coatings, powders, liquids and packaging materials can indicate formulation inconsistencies, contamination risks or manufacturing deviations. To improve accuracy and reduce subjective visual inspection, pharmaceutical manufacturers increasingly rely...

A long-term development and commercial manufacturing agreement has been signed between Shilpa Medicare Limited and Switzerland-based NXI Therapeutics AG, extending the Indian pharmaceutical company’s role in global biologics and specialty therapeutics manufacturing. The agreement covers comprehensive chemistry, manufacturing and...

Swiss pharmaceutical company Novartis has started construction of a new manufacturing facility in Denton, Texas, as part of its previously announced $23 billion investment plan aimed at expanding research and production operations across the United States. The project, expected...

Achieving optimal efficiency in pharmaceutical transport requires an uncompromising focus on transparency. Real-time visibility provides the necessary tools for connected tracking and thermal monitoring, ensuring that drug distribution systems remain secure and effective. By providing continuous oversight of the supply chain, these technologies allow for immediate intervention and data-driven optimization, protecting the integrity of life-saving medications throughout their entire journey.

Holista Colltech Limited has entered into a binding joint venture agreement with Swang Chai Chuan Limited to establish and operate an ovine nano-collagen manufacturing facility in Collie, Western Australia. The project will be carried out through Ovicoll Pty Ltd,...